Cargando…
Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956941/ https://www.ncbi.nlm.nih.gov/pubmed/26990223 http://dx.doi.org/10.1111/jcmm.12833 |
_version_ | 1782444110131494912 |
---|---|
author | Leri, Manuela Bemporad, Francesco Oropesa‐Nuñez, Reinier Canale, Claudio Calamai, Martino Nosi, Daniele Ramazzotti, Matteo Giorgetti, Sofia Pavone, Francesco S. Bellotti, Vittorio Stefani, Massimo Bucciantini, Monica |
author_facet | Leri, Manuela Bemporad, Francesco Oropesa‐Nuñez, Reinier Canale, Claudio Calamai, Martino Nosi, Daniele Ramazzotti, Matteo Giorgetti, Sofia Pavone, Francesco S. Bellotti, Vittorio Stefani, Massimo Bucciantini, Monica |
author_sort | Leri, Manuela |
collection | PubMed |
description | The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with respect to the wild‐type protein. In this study, we characterized the D76N b2M aggregation path and performed an unprecedented analysis of the biochemical mechanisms underlying aggregate cytotoxicity. We showed that, contrarily to what expected from other amyloid studies, early aggregates of the mutant are not the most toxic species, despite their higher surface hydrophobicity. By modulating ganglioside GM1 content in cell membrane or synthetic lipid bilayers, we confirmed the pivotal role of this lipid as aggregate recruiter favouring their cytotoxicity. We finally observed that the aggregates bind to the cell membrane inducing an alteration of its elasticity (with possible functional unbalance and cytotoxicity) in GM1‐enriched domains only, thus establishing a link between aggregate‐membrane contact and cell damage. |
format | Online Article Text |
id | pubmed-4956941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49569412016-08-03 Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin Leri, Manuela Bemporad, Francesco Oropesa‐Nuñez, Reinier Canale, Claudio Calamai, Martino Nosi, Daniele Ramazzotti, Matteo Giorgetti, Sofia Pavone, Francesco S. Bellotti, Vittorio Stefani, Massimo Bucciantini, Monica J Cell Mol Med Original Articles The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with respect to the wild‐type protein. In this study, we characterized the D76N b2M aggregation path and performed an unprecedented analysis of the biochemical mechanisms underlying aggregate cytotoxicity. We showed that, contrarily to what expected from other amyloid studies, early aggregates of the mutant are not the most toxic species, despite their higher surface hydrophobicity. By modulating ganglioside GM1 content in cell membrane or synthetic lipid bilayers, we confirmed the pivotal role of this lipid as aggregate recruiter favouring their cytotoxicity. We finally observed that the aggregates bind to the cell membrane inducing an alteration of its elasticity (with possible functional unbalance and cytotoxicity) in GM1‐enriched domains only, thus establishing a link between aggregate‐membrane contact and cell damage. John Wiley and Sons Inc. 2016-03-18 2016-08 /pmc/articles/PMC4956941/ /pubmed/26990223 http://dx.doi.org/10.1111/jcmm.12833 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Leri, Manuela Bemporad, Francesco Oropesa‐Nuñez, Reinier Canale, Claudio Calamai, Martino Nosi, Daniele Ramazzotti, Matteo Giorgetti, Sofia Pavone, Francesco S. Bellotti, Vittorio Stefani, Massimo Bucciantini, Monica Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title_full | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title_fullStr | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title_full_unstemmed | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title_short | Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
title_sort | molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956941/ https://www.ncbi.nlm.nih.gov/pubmed/26990223 http://dx.doi.org/10.1111/jcmm.12833 |
work_keys_str_mv | AT lerimanuela molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT bemporadfrancesco molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT oropesanunezreinier molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT canaleclaudio molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT calamaimartino molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT nosidaniele molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT ramazzottimatteo molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT giorgettisofia molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT pavonefrancescos molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT bellottivittorio molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT stefanimassimo molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin AT bucciantinimonica molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin |